Fenfluramine: New Treatment for Seizures in Dravet Syndrome.
By: Joanna Garcia Pierce and Divakar S Mithal
References
- Lagae L Sullivan J Knupp K Laux L Polster T Nikanorova M FAiRE DS Study Group. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial Lancet 2020 Dec 394 10216 2243 54 https://doi.org/10.1016/S0140-6736(19)32500-0 31862249
- Polster T Individualized treatment approaches: Fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome Epilepsy Behav 2019 Feb 91 99 102 https://doi.org/10.1016/j.yebeh.2018.08.021 30269941
- Sourbron J Smolders I de Witte P Lagae L Pharmacological analysis of the anti-epileptic mechanisms of fenfluramine in scn1a mutant zebrafish Front Pharmacol 2017 Apr 8 APR 191 https://doi.org/10.3389/fphar.2017.00191 28428755
-
Cross
JH
Caraballo
RH
Nabbout
R
Vigevano
F
Guerrini
R
Lagae
L
Dravet syndrome: treatment options and management of prolonged seizures
Epilepsia
2019
Dec
60
S3 Suppl 3 S39 48 https://doi.org/10.1111/epi.16334 31904119 - Ceulemans B Schoonjans AS Marchau F Paelinck BP Lagae L Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine Epilepsia 2016 Jul 57 7 e129 34 https://doi.org/10.1111/epi.13407 27197941
DOI: https://doi.org/10.15844/pedneurbriefs-34-8 | Journal eISSN: 2166-6482
Language: English
Page range: 8 - 8
Submitted on: Feb 24, 2020
Accepted on: Mar 9, 2020
Published on: Mar 12, 2020
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2020 Joanna Garcia Pierce, Divakar S Mithal, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.